Publication: Research › Patent – Annual report year: 2012
The present invention relates to methods for predicting response of a cancer in a subject to anti-cancer therapies based upon a determination and analysis of a chromosomal aberration score, such as the number of allelic imbalance or the number of telomeric allelic imbalance in the chromosomes of the human genome.
|Country||International Bureau of the World Intellectual Property Organization (WIPO)|
|State||Published - 2013|
No data available